Naloxone Market Report: Trends, Forecast and Competitive Analysis to 2030
Get it in 2 to 4 weeks by ordering today
Naloxone Trends and Forecast
The future of the global naloxone market looks promising with opportunities in the hospital, clinic, retail pharmacy, emergency medical, service, military facility, miscellaneous facility, and online pharmacy markets. The global naloxone market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 10.8% from 2024 to 2030. The major drivers for this market are growing dependency on drugs and opioids overdose, rising public awareness of opioid addiction and overdose prevention, and rising government initiatives for naloxone distribution.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Naloxone by Segment
The study includes a forecast for the global naloxone by strength, route of administration, distribution channel, and region.
Naloxone Market by Strength [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies naloxone companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the naloxone companies profiled in this report include-
Lucintel forecasts that intranasal is expected to witness the highest growth over the forecast period because it is easy to use, safe and increasingly available.
North America is expected to witness highest growth over the forecast period due to growing product launches or approvals by market players, along with the high rate of overdoses and opioid misuse in the area.
Features of the Global Naloxone Market
Market Size Estimates: Naloxone market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Naloxone market size by strength, route of administration, distribution channel, and region in terms of value ($B).
Regional Analysis: Naloxone market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different strength, route of administration, distribution channel, and regions for the naloxone market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the naloxone market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the naloxone market size?
Answer: The global naloxone market is expected to reach an estimated $2.1 billion by 2030.
Q2. What is the growth forecast for naloxone market?
Answer: The global naloxone market is expected to grow with a CAGR of 10.8% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the naloxone market?
Answer: The major drivers for this market are growing dependency on drugs and opioids overdose, rising public awareness of opioid addiction and overdose prevention, and rising government initiatives for naloxone distribution.
Q4. What are the major segments for naloxone market?
Answer: The future of the global naloxone market looks promising with opportunities in the hospital, clinic, retail pharmacy, emergency medical, service, military facility, miscellaneous facility, and online pharmacy markets.
Q5. Who are the key naloxone market companies?
Answer: Some of the key naloxone companies are as follows:
Answer: Lucintel forecasts that intranasal is expected to witness the highest growth over the forecast period because it is easy to use, safe and increasingly available.
Q7. In naloxone market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to growing product launches or approvals by market players, along with the high rate of overdoses and opioid misuse in the area.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the naloxone market by strength (2.0 mg/0.1 ml, 4.0 mg/ml, 1 mg/ml, 0.4 mg/ml, and others), route of administration (intranasal, intramuscular/subcutaneous, and intravenous), distribution channel (hospitals, clinics, retail pharmacies, emergency medical, services, military facilities, miscellaneous facilities, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Naloxone Market, Naloxone Market Size, Naloxone Market Growth, Naloxone Market Analysis, Naloxone Market Report, Naloxone Market Share, Naloxone Market Trends, Naloxone Market Forecast, Naloxone Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Naloxone Trends and Forecast
The future of the global naloxone market looks promising with opportunities in the hospital, clinic, retail pharmacy, emergency medical, service, military facility, miscellaneous facility, and online pharmacy markets. The global naloxone market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 10.8% from 2024 to 2030. The major drivers for this market are growing dependency on drugs and opioids overdose, rising public awareness of opioid addiction and overdose prevention, and rising government initiatives for naloxone distribution.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Naloxone by Segment
The study includes a forecast for the global naloxone by strength, route of administration, distribution channel, and region.
Naloxone Market by Strength [Shipment Analysis by Value from 2018 to 2030]:
- 2.0 mg/0.1 ml
- 4.0 mg/ml
- 1 mg/ml
- 0.4 mg/ml
- Others
- Intranasal
- Intramuscular/Subcutaneous
- Intravenous
- Hospitals
- Clinics
- Retail Pharmacies
- Emergency Medical
- Services
- Military Facilities
- Miscellaneous Facilities
- Online Pharmacies
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies naloxone companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the naloxone companies profiled in this report include-
- Viatris
- Opiant Pharmaceuticals
- Akorn Operating Company
- Pfizer
- Novartis
- Indivior
- Emergent BioSolutions
Lucintel forecasts that intranasal is expected to witness the highest growth over the forecast period because it is easy to use, safe and increasingly available.
North America is expected to witness highest growth over the forecast period due to growing product launches or approvals by market players, along with the high rate of overdoses and opioid misuse in the area.
Features of the Global Naloxone Market
Market Size Estimates: Naloxone market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Naloxone market size by strength, route of administration, distribution channel, and region in terms of value ($B).
Regional Analysis: Naloxone market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different strength, route of administration, distribution channel, and regions for the naloxone market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the naloxone market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the naloxone market size?
Answer: The global naloxone market is expected to reach an estimated $2.1 billion by 2030.
Q2. What is the growth forecast for naloxone market?
Answer: The global naloxone market is expected to grow with a CAGR of 10.8% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the naloxone market?
Answer: The major drivers for this market are growing dependency on drugs and opioids overdose, rising public awareness of opioid addiction and overdose prevention, and rising government initiatives for naloxone distribution.
Q4. What are the major segments for naloxone market?
Answer: The future of the global naloxone market looks promising with opportunities in the hospital, clinic, retail pharmacy, emergency medical, service, military facility, miscellaneous facility, and online pharmacy markets.
Q5. Who are the key naloxone market companies?
Answer: Some of the key naloxone companies are as follows:
- Viatris
- Opiant Pharmaceuticals
- Akorn Operating Company
- Pfizer
- Novartis
- Indivior
- Emergent BioSolutions
Answer: Lucintel forecasts that intranasal is expected to witness the highest growth over the forecast period because it is easy to use, safe and increasingly available.
Q7. In naloxone market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to growing product launches or approvals by market players, along with the high rate of overdoses and opioid misuse in the area.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the naloxone market by strength (2.0 mg/0.1 ml, 4.0 mg/ml, 1 mg/ml, 0.4 mg/ml, and others), route of administration (intranasal, intramuscular/subcutaneous, and intravenous), distribution channel (hospitals, clinics, retail pharmacies, emergency medical, services, military facilities, miscellaneous facilities, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Naloxone Market, Naloxone Market Size, Naloxone Market Growth, Naloxone Market Analysis, Naloxone Market Report, Naloxone Market Share, Naloxone Market Trends, Naloxone Market Forecast, Naloxone Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL NALOXONE MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Naloxone Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Naloxone Market by Strength
3.3.1: 2.0 mg/0.1 ml
3.3.2: 4.0 mg/ml
3.3.3: 1 mg/ml
3.3.4: 0.4 mg/ml
3.3.5: Others
3.4: Global Naloxone Market by Route of Administration
3.4.1: Intranasal
3.4.2: Intramuscular/Subcutaneous
3.4.3: Intravenous
3.5: Global Naloxone Market by Distribution Channel
3.5.1: Hospitals
3.5.2: Clinics
3.5.3: Retail Pharmacies
3.5.4: Emergency Medical
3.5.5: Services
3.5.6: Military Facilities
3.5.7: Miscellaneous Facilities
3.5.8: Online Pharmacies
3.5.9: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Naloxone Market by Region
4.2: North American Naloxone Market
4.2.1: North American Naloxone Market by Route of Administration: Intranasal, Intramuscular/Subcutaneous, and Intravenous
4.2.2: North American Naloxone Market by Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Emergency Medical, Services, Military Facilities, Miscellaneous Facilities, Online Pharmacies, and Others
4.3: European Naloxone Market
4.3.1: European Naloxone Market by Route of Administration: Intranasal, Intramuscular/Subcutaneous, and Intravenous
4.3.2: European Naloxone Market by Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Emergency Medical, Services, Military Facilities, Miscellaneous Facilities, Online Pharmacies, and Others
4.4: APAC Naloxone Market
4.4.1: APAC Naloxone Market by Route of Administration: Intranasal, Intramuscular/Subcutaneous, and Intravenous
4.4.2: APAC Naloxone Market by Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Emergency Medical, Services, Military Facilities, Miscellaneous Facilities, Online Pharmacies, and Others
4.5: ROW Naloxone Market
4.5.1: ROW Naloxone Market by Route of Administration: Intranasal, Intramuscular/Subcutaneous, and Intravenous
4.5.2: ROW Naloxone Market by Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Emergency Medical, Services, Military Facilities, Miscellaneous Facilities, Online Pharmacies, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Naloxone Market by Strength
6.1.2: Growth Opportunities for the Global Naloxone Market by Route of Administration
6.1.3: Growth Opportunities for the Global Naloxone Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Naloxone Market by Region
6.2: Emerging Trends in the Global Naloxone Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Naloxone Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Naloxone Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Viatris
7.2: Opiant Pharmaceuticals
7.3: Akorn Operating Company
7.4: Pfizer
7.5: Novartis
7.6: Indivior
7.7: Emergent BioSolutions
2. GLOBAL NALOXONE MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Naloxone Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Naloxone Market by Strength
3.3.1: 2.0 mg/0.1 ml
3.3.2: 4.0 mg/ml
3.3.3: 1 mg/ml
3.3.4: 0.4 mg/ml
3.3.5: Others
3.4: Global Naloxone Market by Route of Administration
3.4.1: Intranasal
3.4.2: Intramuscular/Subcutaneous
3.4.3: Intravenous
3.5: Global Naloxone Market by Distribution Channel
3.5.1: Hospitals
3.5.2: Clinics
3.5.3: Retail Pharmacies
3.5.4: Emergency Medical
3.5.5: Services
3.5.6: Military Facilities
3.5.7: Miscellaneous Facilities
3.5.8: Online Pharmacies
3.5.9: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Naloxone Market by Region
4.2: North American Naloxone Market
4.2.1: North American Naloxone Market by Route of Administration: Intranasal, Intramuscular/Subcutaneous, and Intravenous
4.2.2: North American Naloxone Market by Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Emergency Medical, Services, Military Facilities, Miscellaneous Facilities, Online Pharmacies, and Others
4.3: European Naloxone Market
4.3.1: European Naloxone Market by Route of Administration: Intranasal, Intramuscular/Subcutaneous, and Intravenous
4.3.2: European Naloxone Market by Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Emergency Medical, Services, Military Facilities, Miscellaneous Facilities, Online Pharmacies, and Others
4.4: APAC Naloxone Market
4.4.1: APAC Naloxone Market by Route of Administration: Intranasal, Intramuscular/Subcutaneous, and Intravenous
4.4.2: APAC Naloxone Market by Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Emergency Medical, Services, Military Facilities, Miscellaneous Facilities, Online Pharmacies, and Others
4.5: ROW Naloxone Market
4.5.1: ROW Naloxone Market by Route of Administration: Intranasal, Intramuscular/Subcutaneous, and Intravenous
4.5.2: ROW Naloxone Market by Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Emergency Medical, Services, Military Facilities, Miscellaneous Facilities, Online Pharmacies, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Naloxone Market by Strength
6.1.2: Growth Opportunities for the Global Naloxone Market by Route of Administration
6.1.3: Growth Opportunities for the Global Naloxone Market by Distribution Channel
6.1.4: Growth Opportunities for the Global Naloxone Market by Region
6.2: Emerging Trends in the Global Naloxone Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Naloxone Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Naloxone Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Viatris
7.2: Opiant Pharmaceuticals
7.3: Akorn Operating Company
7.4: Pfizer
7.5: Novartis
7.6: Indivior
7.7: Emergent BioSolutions
